Sage Journals: Discover world-class research

Retricted access

Review article

First published 1991-2

The Postantibiotic Effect: A Review of in Vitro and in Vivo Data

George G. Zhanel, Daryl J. Hoban, Godfrey K.M. Harding

Annals of Pharmacotherapy

Open access

Research article

First published 2016

Extended-Interval Aminoglycoside Use in Cystic Fibrosis Exacerbation in Children and Young Adults

Khalid H. Safi, Justina M. Damiani, Julie Sturza [...]

Sage Open Pediatrics

Retricted access

Other

First published 2003-10

Pharmacokinetic/Pharmacodynamic Considerations in Community-Acquired Lower Respiratory Tract Infections

Candace Smith

Journal of Pharmacy Practice

Retricted access

Research article

First published 1993-1

Single Daily Dose of Aminoglycosides in the Treatment of Continuous Ambulatory Peritoneal Dialysis Peritonitis

Stephen I. Vas

Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis

Free access

Research article

First published 2000-5

In Vitro Activity of Difloxacin against Canine Bacterial Isolates

R. van den Hoven, J. A. Wagenaar, R. D. Walker

Journal of Veterinary Diagnostic Investigation

Retricted access

Research article

First published 1995-10

Quinupristin/Dalfopristin: Spectrum of Activity,Pharmacokinetics,and Initial Clinical Experience

Donald E. Low

Microbial Drug Resistance

Retricted access

Research article

First published 1989-10

Alternative Dosing Strategy for Aminoglycosides: Impact on Efficacy,Nephrotoxicity,and Ototoxicity

Gary L.C. Chan

Annals of Pharmacotherapy

Retricted access

Research article

First published 1987-1

Potential Impact of Quantitative Susceptibility Tests on the Design of Aminoglycoside Dosing Regimens

James P. McCormack, Jerome J. Schentag

Annals of Pharmacotherapy

Retricted access

Research article

First published 2002-04

Extended-Interval Dosing of Aminoglycoside Antibiotics in Critically Ill Patients

Douglas N. Fish

Journal of Pharmacy Practice

Retricted access

Research article

First published 2022-06

Bacteriophage–Ciprofloxacin Combination Effectiveness Depends on Staphylococcus aureus – Candida albicans Dual-Species Communities’ Growth Model

Marta Roszak, Barbara Dołęgowska, Elżbieta Cecerska-Heryć [...]

Microbial Drug Resistance

Search results